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Abstract
This study examines the adhesion, spreading, and migration of human umbilical vein endothelial
cells on crosslinked films of artificial extracellular matrix (aECM) proteins. The aECM proteins
described here were designed for application in small-diameter grafts and are composed of elastin-
like structural repeats and fibronectin cell-binding domains. aECM-RGD contains the RGD sequence
derived from fibronectin; the negative control protein aECM-RDG contains a scrambled cell-binding
domain. Covalent attachment of poly(ethylene glycol) (PEG) to aECM substrates reduced
nonspecific cell adhesion to aECM-RDG-PEG but did not preclude sequence-specific adhesion of
endothelial cells to aECM-RGD-PEG. Variation in ligand density was accomplished by mixing
aECM-RGD-PEG and aECM-RDG-PEG prior to crosslinking. Increasing the density of RGD
domains in crosslinked films resulted in more robust cell adhesion and spreading but did not affect
cell migration speed. Control of cell-binding domain density in aECM proteins can thus be used to
modulate cell adhesion and spreading, and will serve as an important design tool as these materials
are developed further for use in surgery, tissue engineering and regenerative medicine.
Introduction
A central goal of research in tissue engineering and regenerative medicine is the design of
biomaterials that can be used to control critical aspects of cellular behavior. Such materials
might guide seeded cells toward the phenotypes and architectures needed to restore tissue
function, or induce cells from surrounding tissue to infiltrate implanted matrices. An important
step toward these goals has been taken through grafting of RGD and other cell adhesion
sequences to polymeric matrices.1 Cell proliferation, adhesion, spreading, migration, and
differentiation are influenced by the overall density of matrix-bound RGD peptides2-5 as well
as by nanoscale ligand clustering.6-9 Biochemical gradients have also been shown to govern
haptotaxis, cell distribution, and cell alignment.10-12
Genetic engineering of proteins offers a straightforward route to materials that exhibit some
of the most important chemical and physical properties of the extracellular matrix (ECM).
Structural and functional domains derived from ECM proteins can be incorporated easily into
engineered proteins, and many artificial protein-based materials have been developed for use
in tissue engineering applications.13-21
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The artificial extracellular matrix (aECM) proteins described in this work were designed for
use in small-diameter vascular grafts.22-30 Although poly(ethylene terephthalate) and
expanded poly(tetrafluoroethylene) have been successful in large-diameter grafts, their use in
small-diameter grafts has been problematic.31-34 Synthetic grafts are thought to fail because
of (i) the absence of a confluent endothelial layer and (ii) a compliance mismatch between the
graft and surrounding tissue that leads to intimal hyperplasia and thrombosis. To address these
issues, aECM proteins were designed with elastin-like repeats to confer elastomeric properties
and with cell-binding domains to promote endothelialization (Figure 1). By crosslinking
through lysine residues within the elastin-like domains, we have varied the elastic moduli of
aECM protein films from ca. 0.1 to 1.0 MPa, an appropriate range for many soft-tissue
applications.23 Furthermore, the design allows for facile incorporation of different cell-binding
domains, and previous work has elucidated cellular responses to the fibronectin-derived RGD
and CS5 domains in adsorbed aECM proteins.24, 26, 28, 29 aECM proteins thus allow good
control over both biophysical and biochemical cues; however, because many applications of
aECM proteins will require the use of crosslinked matrices, it is essential to understand cellular
responses to crosslinked aECM films.
In this study, we present a method for preparing crosslinked aECM films suitable for cell
studies, and we demonstrate that cells recognize the RGD sequence within crosslinked,
PEGylated protein films. We vary the density of adhesion ligands by mixing aECM-RGD and
aECM-RDG prior to crosslinking, and we examine the role of RGD density in modulating the
adhesion, spreading, and migration of human umbilical vein endothelial cells.
Materials and Methods
Protein Expression and Purification
aECM-RGD and aECM-RDG were expressed in Escherichia coli and purified via temperature
cycling as described previously.26 The purity and molecular weight of the proteins were
verified by SDS-PAGE gels, Western blots with an anti-T7 tag horseradish peroxidase-
conjugated antibody (Novagen, San Diego, CA), amino acid analysis, and matrix-assisted laser
desorption ionization-mass spectrometry (MALDI-MS).
Cell Culture
Human umbilical vein endothelial cells (HUVECs) were purchased from Cambrex
BioSciences (Walkersville, MD) and maintained in a 37°C, 5% CO2 humidified environmental
chamber. Cells were grown in endothelial growth medium-2 (EGM-2, 2% serum, Cambrex
BioSciences); passages 2–7 were used. Near confluent HUVEC cultures were non-
enzymatically detached by treatment with 0.61 mM EDTA.
Substrate Preparation
A 12 mm base-cleaned glass coverslip was covered with 20 μL of an aqueous aECM protein
solution (3.6 mg/mL) containing the bifunctional crosslinker bis(sulfosuccinimidyl) suberate
(BS3, Pierce Biotechnology, Rockford, IL). The molar ratio of activated ester to protein-bound
amine was 1:4. To slow the rate of crosslinking, protein solutions and coverslips were kept on
ice. Coverslips were spin-coated at 4000 rpm for 45 s on a Specialty Coating Systems model
P-6000 spin coater and stored overnight in a humidified chamber at 4°C. To covalently attach
polyethylene glycol (PEG) to aECM films, 50 μL of a 50 mM methoxy-PEG-succinimidyl
propionate (mPEG-SPA, MW 5000, Nektar Therapeutics, San Carlos, CA) solution in water
was placed on parafilm and the coverslips were placed protein-side down in the PEG solution.
The coverslips were incubated for 2 h at room temperature, rinsed three times with water,
sterilized with 95% ethanol for 1 h, and rinsed three times with water.
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Substrate Characterization
To ensure uniformity, crosslinked protein films were examined via fluorescence microscopy.
Films were blocked with 10% bovine serum albumin (BSA, fraction V, Sigma, St. Louis, MO)
and incubated with an anti-T7 monoclonal antibody (Novagen) at a dilution of 1:2000 at room
temperature overnight. After three water rinses, films were incubated with a Cy2-conjugated
affinity-purified goat anti-mouse antibody (Chemicon, Temecula, CA) at a dilution of 1:10 for
1 h at room temperature. Coverslips were rinsed four times with water and examined on a Zeiss
Axioplan II fluorescence microscope (Thornwood, NY) equipped with a monochrome
Axiocam and AxioVision 3.1 software.
Crosslinked protein films were scratched with a razor blade to reveal the underlying glass
substrate. Height was measured by imaging over the scratch with an AutoProbe M5 atomic
force microscope (Park Scientific Instruments, Woodbury, NY) in constant-force contact
mode, using pyramidal tips (0.58 N/m, Veeco DNP-S).
An M-probe surface spectrometer (Thermo VG Scientific, Waltham, MA) with
monochromatic Al Kα x-rays (1486.6 eV) was used for x-ray photoelectron spectroscopy
(XPS). X-rays at an incident angle of 35° from the surface illuminated a 250 × 1000 μm
elliptical spot. A charge neutralizer was used because the samples were non-conductive. Ten
detailed peak scans were collected with an instrument resolution of 1 eV and a step size of 0.1
eV. The ESCA 2000 analysis software v. 102.04 (Service Physics, Bend, OR) was used for
peak integration. Three spots were analyzed on each substrate, and at least three substrates
were examined for each condition.
Cell viability on crosslinked aECM proteins was measured by monitoring the cleavage of the
tetrazolium salt WST-1 (Roche, Penzberg, Germany). After 24 h in serum-containing medium
(EGM-2), there were no differences in viability between cells grown on aECM-RGD-PEG and
those grown on fibronectin. The viability of cells grown on the negative control protein aECM-
RDG-PEG was 43 ± 10% of the viability of cells grown on fibronectin. Three independent
experiments were performed, each in triplicate.
Cell Resistance to Detachment
Experiments to measure cell resistance to detachment by normal forces were adapted from a
previously described method.26 Briefly, a fibronectin solution (10 μg/mL) was adsorbed onto
control wells in a black 24-well Visiplate (Perkin Elmer, Wellesley, MA) at 4°C overnight.
All wells were blocked with 0.2% heat-inactivated BSA. Vacuum grease was applied to the
undersides of dry coverslips to adhere them securely to the 24-well plate. After cells were
fluorescently labeled with calcein acetoxymethyl ester (Molecular Probes, Carlsbad, CA), 1
mL of a cell suspension (2.67 × 105 cells/mL in serum-free medium) was added to each well
and incubated for 30 min on crosslinked protein films. The relative numbers of cells were
measured by fluorescence (excitation at 485 nm; emission at 538 nm). Each well was filled
with 1 mL of Percoll (21% w/w in PBS, Sigma), and the plates were centrifuged upright for
10 min at 100g. Because Percoll has a higher density (1.123 g/ml) than the cells (∼1.07 g/ml),
a buoyancy force is exerted on the cells.8, 35 By using Archimedes' theorem, we estimated the
detachment force applied to each cell to be 26 pN. The liquid and non-adherent cells were
removed, and the remaining cells were quantified by fluorescence. The fraction of cells retained
in each well was calculated by dividing the fluorescence of the remaining cells by the
fluorescence of the cells before centrifugation. A cell adhesion index (CAI) was calculated as
the fraction of cells retained in a test well divided by the fraction of cells retained on fibronectin
subjected to 1g (0.26 pN). Error bars represent standard deviations of three or more independent
experiments, each performed in triplicate. A one-tailed two-sample t-test that assumed equal
variances was applied to determine statistical significance.
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Cell Spreading
HUVECs in serum-free medium were seeded at a concentration of 4.8 × 104 cells per well in
a 6-well plate. Cells on crosslinked aECM films were imaged at 15 min intervals by using a
10× phase contrast objective on a Nikon Eclipse TE300 inverted microscope. Images were
manually scored for the number of spread (i.e., dark) versus non-spread (i.e., bright and
refractive) cells. Three independent experiments were performed.
Cell Migration
Cells in EGM-2 were added to each well of a 6-well plate at densities of 1.6 × 104 to 6 × 104
cells per well. The cells were allowed to adhere for 2 h, after which they were imaged using a
Nikon Eclipse TE300 inverted phase contrast microscope surrounded by a 37°C incubation
box. To maintain physiological pH, a humidified gas mixture of 5% CO2, 20% O2, and 75%
N2 was continuously bubbled through the 6-well plate. Teflon tape was used to seal the plate
and a thin layer of mineral oil (embryo-tested, Sigma) was added to the top of the medium to
prevent evaporation. Cells at various locations were recorded every 15 min for 24 h using a
motorized stage and the MetaMorph Basic Imaging Software (Molecular Devices,
Downingtown, PA).
The image sequences were imported into ImageJ 1.30v software (U.S. National Institutes of
Health, Bethesda, MD) and saved as Quicktime files. Dynamic Image Analysis Software
(DIAS) 3.2 (Solltech, Oakdale, IA) was used to analyze the Quicktime movies. The images
were thresholded to automatically trace cells. The outlines were then manually edited to erase
incorrectly outlined areas and to adjust some tracings. Only cells that were well-spread,
isolated, and tracked for at least 8 h were included in the analysis. At least three independent
experiments were performed with a minimum of 80 cells tracked in total for each substrate.
Results and Discussion
Substrate Characterization
Protein films were prepared with a molar ratio of activated ester to protein-bound amine of
1:4. Under these conditions, quantitative intermolecular aminolysis of BS3 would yield 4.25
crosslink sites per protein. Several molar ratios were tested to ensure that crosslinking produced
coherent films containing residual amine sites for subsequent coupling to poly(ethyleneglycol).
Film thickness was typically 8–10 nm as measured by atomic force microscopy (AFM) after
dehydration. Fluorescence imaging was used to verify film uniformity. When washed with
water or with 0.05% sodium dodecyl sulfate (SDS), crosslinked protein films remained uniform
and coherent; spin-coated protein films prepared in the absence of BS3 did not.
PEGylation of Crosslinked aECM Films
Grafting of poly(ethyleneglycol) (PEG) was used to reduce nonspecific adhesion of cells to
crosslinked aECM films. The extent of PEGylation was assessed by X-ray photoelectron
spectroscopy (XPS) (see Supporting Information). After incubation of films with mPEG-SPA
(MW 5000) for 2 h, XPS indicated an average grafting density of ca. 1.8 PEG molecules per
protein chain. Longer reaction times yielded no further increase in grafting density. When a
PEG variant with no reactive ends (MW 4600) was used, the amount of PEG detected on the
surface was equivalent to ca. 0.2 PEG molecules associated with each protein strand. Covalent
attachment through lysine residues is necessary for effective PEGylation of aECM films.
We showed previously that cell adhesion to adsorbed (uncrosslinked) aECM proteins is
dependent upon presentation of authentic cell-binding domains.26 In contrast, in the absence
of PEGylation, crosslinked protein films exhibit significant nonspecific adhesion. HUVECs
were incubated on crosslinked substrates for 30 min and then subjected to a 26 pN normal
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detachment force for 10 min. On films without PEG modification, aECM-RDG retained nearly
as many cells as aECM-RGD (Figure 2). On PEGylated films, nearly 4-fold more cells were
retained on aECM-RGD as compared to aECM-RDG. PEGylated films are designated aECM-
RGD-PEG and aECM-RDG-PEG, respectively. The high cell adhesion index (CAI) for aECM-
RDG (76.9 ± 6.0%) indicates significant nonspecific adhesion in the absence of an authentic
cell-binding domain. The CAI was reduced to 21.2 ± 7.8% when cells were seeded on aECM-
RDG-PEG. All further studies were conducted with PEGylated crosslinked films.
HUVEC Resistance to Detachment Forces
Crosslinked films prepared from mixtures of aECM-RGD-PEG and aECM-RDG-PEG were
used to determine the role of RGD density in controlling cell adhesion. For films containing
0–1% aECM-RGD-PEG, the CAI was low (16–21%), but significantly higher than the CAI
on the negative control protein BSA (2.0 ± 3.0%). As the fraction of aECM-RGD-PEG was
raised from 0.05 to 1.0, the CAI increased from 51.1 ± 28.8% to 96.0 ± 21.3%. Films containing
aECM-RGD-PEG fractions greater than 0.25 were not statistically different (p ≤ 0.5) from
fibronectin controls (CAI 91.3 ± 27.0%).
Based on the density of elastin (1.31 g/mL)36 and a polymer weight fraction of 0.56,27 the
concentration of cell-binding domains in a 10 nm-thick near-surface layer of a hydrated,
crosslinked aECM-RGD film is estimated as 3.8 × 105 per μm2 (CBD/μm2). Previous studies
have shown that ligand densities ranging from 102 to 104 CBD/μm2 are adequate to support
cell adhesion.8, 37, 38 The results shown in Figure 3 suggest that roughly 104 CBD/μm2 are
required for significant adhesion to aECM-RGD-PEG. Houseman and Mrksich have examined
the role of peptide microenvironment in modulating cell adhesion; for RGD peptides appended
to oligo(ethylene glycol) monolayers, cell adhesion was found to be increasingly sensitive to
ligand density as the oligomers were extended from three EO units to six.38 The PEG chains
used in the present work are much longer (> 100 units), and our assumption of an accessible
thickness of 10 nm is arbitrary. The effective ligand densities in aECM-RGD-PEG films
therefore may be significantly lower than our estimates; nevertheless, it appears that the ligand
density required for cell adhesion on such films falls near the high end of the range of values
reported previously.
HUVEC Spreading on Crosslinked aECM Films
Cell spreading on crosslinked aECM films is dependent on the density of RGD domains.
HUVECs plated on PEGylated films were monitored at 15 min intervals by phase contrast
microscopy and categorized as dark (spread) or bright (rounded). On films containing 50–100%
aECM-RGD-PEG, half of the cells spread within 60–90 min (Figure 4). When compared to
the positive control, fibronectin, the percentage of well-spread cells on 100% aECM-RGD-
PEG was statistically lower at all time points (p-values < 0.03). Reducing the aECM-RGD-
PEG content resulted in significant reduction in the extent of cell spreading; fewer than 1% of
cells spread on aECM films containing no authentic cell-binding sequences. Comparison of
the percentages of well-spread cells on 50-100% aECM-RGD-PEG films versus those on 0%
aECM-RGD-PEG gave p-values < 0.05 at 30-120 min. Similar comparisons for cells on 25%
and 10% aECM-RGD-PEG films gave p-values < 0.05 at time points greater than or equal to
45 or 105 min, respectively. No significant differences between 5% aECM-RGD-PEG and
negative control films were observed.
HUVEC Migration Rates
A phase contrast microscope outfitted with a motorized stage and an environmental chamber
was used to track cells every 15 min for a minimum of 8 h. Migration rate was calculated as
the distance traveled divided by the tracking time. Measured HUVEC speeds ranged from 0.45
to 0.55 μm/min but did not depend on the concentration of cell-binding ligand. Published values
Liu and Tirrell Page 5
Biomacromolecules. Author manuscript; available in PMC 2009 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
for endothelial cells migrating on fibronectin or RGD peptides range from 0.25 to 0.67 μm/
min;39-43 the migration speeds measured in this study fall within the upper half of reported
values. Although previous studies have shown that cell migration rates can, under some
circumstances, vary in a biphasic manner with substrate adhesiveness,9, 42, 44 cells on aECM-
RGD-PEG films did not exhibit such behavior.
Conclusion
We report a simple method for making crosslinked aECM films suitable for cell studies. By
mixing otherwise identical proteins that contain authentic and scrambled cell-adhesion ligands,
we fix all of the physical and chemical properties of the films while varying only their biological
information content. Crosslinked, PEGylated protein substrates show low levels of nonspecific
cell adhesion but retain the ability to bind cells in a sequence-specific manner. Moreover, by
varying the concentration of authentic cell-binding domains in the protein films, we were able
to modulate cell adhesion and spreading, but not cell migration rate. Current work addresses
the importance of ligand presentation and mechanical properties in modulating cellular
responses to aECM proteins and the relevance of aECM proteins to clinical soft-tissue
engineering.
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Figure 1.
Amino acid sequences of aECM proteins. aECM-RGD contains the RGD cell-binding domain.
aECM-RDG is a negative control protein in which the cell-binding domain has been scrambled.
Both proteins contain a T7 tag, a heptahistidine tag, an enterokinase cleavage site, and elastin-
like domains with lysine residues that serve as crosslinking sites.
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Figure 2.
PEGylation reduces nonspecific cell adhesion on aECM films. See text for definition of cell
adhesion index. Data represent three experiments, each performed in triplicate. Error bars
represent one standard deviation. * represents p < 0.01.
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Figure 3.
HUVEC resistance to detachment forces. By raising the concentration of aECM-RGD-PEG,
the number of adherent cells can be increased. Crosslinked films were made by mixing aECM-
RGD-PEG and aECM-RDG-PEG. Data represent three experiments, each performed in
triplicate. Error bars represent one standard deviation.
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Figure 4.
HUVEC spreading on crosslinked aECM films. Cell spreading kinetics can be modulated by
varying the density of adhesion ligands. Fibronectin (□) and BSA controls (○) are represented
by dotted lines. The percentages to the right of the traces indicate the percentage of aECM-
RGD-PEG in each film. Phase contrast micrographs show that substrates with higher aECM-
RGD-PEG content have a larger number of dark, well-spread cells and fewer bright, rounded
cells after 90 min of incubation. Scale bar represents 200 μm. Data represent three experiments.
Error bars represent one standard deviation.
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Figure 5.
HUVEC migration on aECM substrates. Cell speed on aECM films does not correlate with
aECM-RGD-PEG concentration. At least 80 cells were tracked every 15 min for at least 8 h.
Error bars represent one standard deviation.
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